Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Enokida

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|October 29, 2020
Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal CarcinomaYuri Ueda, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology|June 16, 2017
Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case seriesTomohiro Enokida, Shinya Uozumi, Takao Fujisawa, et al.
Frontiers in Oncology|September 30, 2016
Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with CetuximabTomohiro Enokida, Shinya Suzuki, Tetsuro Wakasugi, et al.
Cureus|August 1, 2025
A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown PrimaryKyosuke Seguchi, Tomohiro Enokida, Toshiki Oba, et al.
Pathology International|July 21, 2016
Combined salivary duct carcinoma and squamous cell carcinoma suspected of carcinoma ex pleomorphic adenomaTomohiro Enokida, Satoshi Fujii, Hirofumi Kuno, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Landscape of natural killer cell activity in head and neck squamous cell carcinomaAndrew J Charap, Tomohiro Enokida, Rachel Brody, et al.
International Journal of Clinical Oncology|February 24, 2019
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancerSusumu Okano, Tomohiro Enokida, Takuma Onoe, et al.
Frontiers in Oncology|October 27, 2023
Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective studyChihiro Matsuyama, Tomohiro Enokida, Yuri Ueda, et al.
Japanese Journal of Clinical Oncology|June 19, 2016
Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiationTomoko Yamazaki, Tomohiro Enokida, Tetsuro Wakasugi, et al.
SAGE Open Medicine|January 16, 2016
Evaluation of the impact of a flowchart-type leaflet for cancer inpatientsShinya Suzuki, Tomohiro Enokida, Takehiko Kobayashi, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|October 29, 2020
Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal CarcinomaYuri Ueda, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology|June 16, 2017
Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case seriesTomohiro Enokida, Shinya Uozumi, Takao Fujisawa, et al.
Frontiers in Oncology|September 30, 2016
Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with CetuximabTomohiro Enokida, Shinya Suzuki, Tetsuro Wakasugi, et al.
Cureus|August 1, 2025
A Case of Micro-medullary Thyroid Carcinoma Presenting as Cancer of Unknown PrimaryKyosuke Seguchi, Tomohiro Enokida, Toshiki Oba, et al.
Pathology International|July 21, 2016
Combined salivary duct carcinoma and squamous cell carcinoma suspected of carcinoma ex pleomorphic adenomaTomohiro Enokida, Satoshi Fujii, Hirofumi Kuno, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Landscape of natural killer cell activity in head and neck squamous cell carcinomaAndrew J Charap, Tomohiro Enokida, Rachel Brody, et al.
International Journal of Clinical Oncology|February 24, 2019
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancerSusumu Okano, Tomohiro Enokida, Takuma Onoe, et al.
Frontiers in Oncology|October 27, 2023
Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective studyChihiro Matsuyama, Tomohiro Enokida, Yuri Ueda, et al.
Japanese Journal of Clinical Oncology|June 19, 2016
Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiationTomoko Yamazaki, Tomohiro Enokida, Tetsuro Wakasugi, et al.
SAGE Open Medicine|January 16, 2016
Evaluation of the impact of a flowchart-type leaflet for cancer inpatientsShinya Suzuki, Tomohiro Enokida, Takehiko Kobayashi, et al.
Pageof 7